Brooke Nickel, Low risk cancer communication Carys Batcup 7/10/22 Brooke Nickel, Low risk cancer communication Carys Batcup 7/10/22 Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus? Read More Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 9/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 9/3/22 Terminology change for small low-risk papillary thyroid cancer as a response to overtreatment: results from three Australian community juries Read More Brooke Nickel, Low risk cancer communication Carys Batcup 9/3/22 Brooke Nickel, Low risk cancer communication Carys Batcup 9/3/22 Re-thinking low risk micropapillary thyroid cancer: an evidence review to consider recalibrating diagnostic thresholds and/or alternative labels Read More Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 8/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 8/3/22 Public perceptions of changing the terminology for low risk thyroid cancer: a qualitative focus group study Read More Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Patients' experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study Read More Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Association of preferences for papillary thyroid cancer treatment with disease terminology: a discrete choice experiment Read More Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Effect of a change in papillary thyroid cancer terminology on anxiety levels and treatment preferences: a randomized crossover trial Read More Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Renaming low risk conditions labelled as cancer Read More Brooke Nickel, Kirsten McCaffery, Tessa Copp, Low risk cancer communication Carys Batcup 6/3/22 Brooke Nickel, Kirsten McCaffery, Tessa Copp, Low risk cancer communication Carys Batcup 6/3/22 Words do matter: a systematic review on how different terminology for the same condition influences management preferences Read More Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 6/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 6/3/22 Clinicians’ views on management and terminology for papillary thyroid microcarcinoma: a qualitative study Read More
Brooke Nickel, Low risk cancer communication Carys Batcup 7/10/22 Brooke Nickel, Low risk cancer communication Carys Batcup 7/10/22 Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus? Read More
Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 9/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 9/3/22 Terminology change for small low-risk papillary thyroid cancer as a response to overtreatment: results from three Australian community juries Read More
Brooke Nickel, Low risk cancer communication Carys Batcup 9/3/22 Brooke Nickel, Low risk cancer communication Carys Batcup 9/3/22 Re-thinking low risk micropapillary thyroid cancer: an evidence review to consider recalibrating diagnostic thresholds and/or alternative labels Read More
Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 8/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 8/3/22 Public perceptions of changing the terminology for low risk thyroid cancer: a qualitative focus group study Read More
Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Patients' experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study Read More
Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Association of preferences for papillary thyroid cancer treatment with disease terminology: a discrete choice experiment Read More
Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Effect of a change in papillary thyroid cancer terminology on anxiety levels and treatment preferences: a randomized crossover trial Read More
Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 7/3/22 Renaming low risk conditions labelled as cancer Read More
Brooke Nickel, Kirsten McCaffery, Tessa Copp, Low risk cancer communication Carys Batcup 6/3/22 Brooke Nickel, Kirsten McCaffery, Tessa Copp, Low risk cancer communication Carys Batcup 6/3/22 Words do matter: a systematic review on how different terminology for the same condition influences management preferences Read More
Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 6/3/22 Brooke Nickel, Kirsten McCaffery, Low risk cancer communication Carys Batcup 6/3/22 Clinicians’ views on management and terminology for papillary thyroid microcarcinoma: a qualitative study Read More
